What is CVE-2024-38492?

CVE-2024-38492 is a vulnerability in Broadcom Symantec Privileged Access Management, classified under Command Injection. Published 2024-07-15.

Is CVE-2024-38492 known to be exploited?

2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

RCE in Broadcom Symantec Privileged Access Management

CVE-2024-38492

This vulnerability allows an unauthenticated attacker to achieve remote command execution on the affected PAM system by uploading a specially crafted PAM upgrade file.

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.009 (57.3th percentile) — read the EPSS interpretation.

Affected products

Broadcom Symantec Privileged Access Management — versions 4.1.0 - 4.1.7, 3.4.6

Weakness classification (CWE)

CWE-77 — Command Injection

Public proof-of-concept exploits

ARPSyndicate/cve-scores
fkie-cad/nvd-json-data-feeds

References

secure@symantec.com

Frequently asked questions

What is CVE-2024-38492?: CVE-2024-38492 is a vulnerability in Broadcom Symantec Privileged Access Management, classified under Command Injection. Published 2024-07-15.
Is CVE-2024-38492 known to be exploited?: 2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.